Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00843414 · ClinicalTrials.gov registry record

Immunological Characterization of Bronchoalveolar Cells in Normals

A clinical trial, sponsored by Ohio State University.

Completed
Registry status
1,232
Enrollment target

NCT00843414: Completed study, sponsored by Ohio State University.

NCT00843414 is a clinical trial that has completed, run by Ohio State University. The registered enrollment target is 1,232 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00843414 has completed, sponsored by Ohio State University.

COMPLETED
Registry status
1,232 participants
Enrollment target

Study Summary

To obtain the monocytes (white blood cells) from normal volunteers for the purpose of studying how proteins, fats, carbohydrates, as well as RNA and DNA for gene expression, relate to immunity. This information will be compared to other studies in patients with lung diseases such as Emphysema, Sarcoidosis, and Interstitial Pulmonary Fibrosis.

Trial Details

FieldValue
Enrollment Target 1,232 participants
Start Date 1978-03
Est. Completion 2011-04
Ohio State University

552 total trials

What the finished NCT00843414 record still lists

NCT00843414 is an observational study that tracks outcomes without assigning an intervention. Its 1,232 participants enrollment target places it among the larger protocols in the corpus.

The record links to 0 conditions, and to 0 interventions.

NCT00843414 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00843414 about?

NCT00843414 is a clinical study titled "Immunological Characterization of Bronchoalveolar Cells in Normals". To obtain the monocytes (white blood cells) from normal volunteers for the purpose of studying how proteins, fats, carbohydrates, as well as RNA and DNA for gene expression, relate to immunity. This information will be compared to other studies in patients with lung diseases such as Emphysema, Sarco...

What is the current status of trial NCT00843414?

This trial is currently completed. The enrollment target is 1,232 participants. The study started on 1978-03. Estimated completion is 2011-04.

Who is sponsoring clinical trial NCT00843414?

This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05456841 · 1,232 participants · NA

    Empathic Communication Skills (ECS) Training

  • NCT05946044 · 1,230 participants · NA

    The Osteoarthritis Prevention Study

  • NCT06787937 · 1,230 participants · NA

    Communicating About Nicotine Reduction in Cigarettes

  • NCT06368245 · 1,244 participants

    Durability of Suppl. Rod Constructs-SuppleMentAry Rod Technique for Long-segment Posterior Instrumented Spinal Fusions

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00843414, the US trial registry maintained by the National Library of Medicine. NCT00843414 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.